Fu Ou‐Yang
Impact in
- Aging top 2%
- Genetics, Aging, and Longevity in Model Organisms
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Angiogenesis and VEGF in Cancer 3
- Oncology 14
- Cytokine Signaling Pathways and Interactions 3
- HER2/EGFR in Cancer Research 3
- Global Cancer Incidence and Screening 3
- Co-authors
- Mien‐Chie Hung (5 shared papers)Weiya Xia (3 shared papers)Dung‐Fang Lee (3 shared papers)Ming‐Feng Hou (22 shared papers)Norihisa Hanada (2 shared papers)Shilai Bao (2 shared papers)Leonard S. Golfman (2 shared papers)Hitomi Saso (2 shared papers)
- Journals
- Environmental Toxicology (3 papers)Antioxidants (3 papers)Cell (2 papers)BMC Cancer (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Fu Ou‐Yang
45 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Aging 113
- Cancer Research 401
- Oncology 531
- Molecular Biology 1.3k
- Geriatrics and Gerontology 59
Countries citing papers authored by Fu Ou‐Yang
This map shows the geographic impact of Fu Ou‐Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Ou‐Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Ou‐Yang more than expected).
Fields of papers citing papers by Fu Ou‐Yang
This network shows the impact of papers produced by Fu Ou‐Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Ou‐Yang. The network helps show where Fu Ou‐Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Ou‐Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a Hit paper breakdown → | 2004 | 742 |
| 2 | 2004 | 241 | |
| 3 | 2018 | 178 | |
| 4 | 2006 | 111 | |
| 5 | 2022 | 51 | |
| 6 | 2018 | 50 | |
| 7 | 2006 | 47 | |
| 8 | 2002 | 40 | |
| 9 | 2021 | 39 | |
| 10 | 2020 | 33 | |
| 11 | 2010 | 31 | |
| 12 | 2019 | 30 | |
| 13 | 2022 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2019 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2019 | 20 | |
| 19 | 2019 | 20 | |
| 20 | 2004 | 19 |
About Fu Ou‐Yang
Fu Ou‐Yang is a scholar working on Molecular Biology, Oncology, Complementary and alternative medicine, Cancer Research and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Medicinal Plants and Neuroprotection (6 papers), Breast Lesions and Carcinomas (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), HER2/EGFR in Cancer Research (3 papers), Phytochemicals and Medicinal Plants (3 papers), Breast Cancer Treatment Studies (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Aging (113 citations), Cancer Research (401 citations), Oncology (531 citations), Molecular Biology (1.3k citations) and Geriatrics and Gerontology (59 citations). Fu Ou‐Yang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mien‐Chie Hung, Weiya Xia, Dung‐Fang Lee, Ming‐Feng Hou, Norihisa Hanada, Shilai Bao, Leonard S. Golfman, Hitomi Saso, Mickey C.‐T. Hu and Jer-Yen Yang. Their work appears in journals such as Environmental Toxicology, Antioxidants, Cell, BMC Cancer and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.